2013 PHORG Grant Recipients
Congratulations to the 2013 PHORG Grant Recipients:
"Three-Dimensional Analysis in Children with Hemophilia"
Amy Dunn, MD
"A Phase I Study Using Simvastatin in Combination With Conventional Chemotherapy in Relapsed and/or Refractory Pediatric Solid Tumors"
Kelly Goldsmith, MD
________________________________________
More info about this program:
Pediatric Hematology/Oncology Research Group (PHORG)--
The goal of this pilot project program is to stimulate an environment within the Aflac Cancer and Blood Disorders Center that fosters translational initiatives that can lead to new methods for diagnosing, preventing, and treating disease. Special consideration will be given to proposals that include the development of a clinical trial with a laboratory component. Translational initiatives that include the study of patient samples that will further the development of an innovative clinical initiative will also be strongly considered.
An additional aim of the PHORG grant is to facilitate intra-programmatic collaborations and interactions among the members of the Aflac Cancer Center and Blood Disorders Service. For these reasons, proposals ideally involve collaborative studies between two Aflac faculty members.
________________________________________
For questions, contact:
Todd M. Cooper, DO
Director, Innovative Therapy/Phase I Program
Aflac Cancer & Blood Disorders Center
Children's Healthcare of Atlanta/Emory University
Phone: 404-785-1838
Email: Todd.Cooper@choa.org